![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 16 July 2020
Sec. Pharmacology of Anti-Cancer Drugs
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.01088
This article is a correction to:
Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
A Corrigendum on
Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
by Wang F, Pozo FM. Tian D, Geng X, Yao X, Zhang Y and Tang J (2020) Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction. Front. Pharmacol. 11:861. doi: 10.3389/fphar.2020.00861
In the published article, there was an error regarding the contribution of “Xinsheng Yao,” who should be a co-corresponding author.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Shikonin, anticancer effect, cell cycle arrest, autophagy, apoptosis, P21
Citation: Wang F, Mayca Pozo F, Tian D, Geng X, Yao X, Zhang Y and Tang J (2020) Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction. Front. Pharmacol. 11:1088. doi: 10.3389/fphar.2020.01088
Received: 29 June 2020; Accepted: 03 July 2020;
Published: 16 July 2020.
Copyright © 2020 Wang, Mayca Pozo, Tian, Geng, Yao, Zhang and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinsheng Yao, dHlhb3hzQGpudS5lZHUuY24=; Youwei Zhang, eXh6MTY5QGNhc2UuZWR1; Jinshan Tang, Z3p0YW5namluc2hhbkAxMjYuY29t
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.